Anderson, Amy E <br/><br/>
Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Aug 2012 
 - 1397-406 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kes038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Arthritis, Rheumatoid--complications<br/>B-Lymphocytes--immunology<br/>CD5 Antigens--immunology<br/>Case-Control Studies<br/>Cohort Studies<br/>Female<br/>Flow Cytometry<br/>Follow-Up Studies<br/>Humans<br/>Immunity--physiology<br/>Immunophenotyping<br/>Influenza Vaccines--administration & dosage<br/>Lymphocyte Count<br/>Lymphocyte Depletion<br/>Lymphopenia--drug therapy<br/>Male<br/>Middle Aged<br/>T-Lymphocytes--immunology<br/>Thymus Gland--immunology